RBC Bioscience Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	201.85	205.25	172.47	173.89	251.18	575.16
Revenue Growth (YoY)	3.72%	19.00%	-0.82%	-30.77%	-56.33%	255.74%
Cost of Revenue	104.91	107.17	99.57	100.89	134.11	274.84
Gross Profit	96.94	98.07	72.9	73.01	117.07	300.33
Selling, General & Admin	52.1	52.42	47.41	49.61	52.44	89.71
Research & Development	11.54	9.86	10.84	15.74	16.39	22.24
Operating Expenses	64.02	62.69	58.36	65.26	68.46	112.54
Operating Income	32.93	35.38	14.54	7.75	48.61	187.79
Interest Expense	-10.17	-10.31	-10	-7.57	-6.33	-1.18
Interest & Investment Income	0.46	0.5	0.36	0.16	0.17	0.14
Other Non Operating Income (Expenses)	4.67	2.88	3	4.57	-5.98	-9.49
EBT Excluding Unusual Items	27.89	28.45	7.89	4.91	36.48	177.25
Gain (Loss) on Sale of Assets	0	0	-0.02	0.01	-0.54	0.09
Legal Settlements	-2.99	-1.49	-	-	-	-
Other Unusual Items	-	-	-	-	0.01	-
Pretax Income	24.9	26.96	7.87	4.92	35.95	177.34
Income Tax Expense	5.31	5.4	1.44	1.14	7.22	35.44
Net Income	19.59	21.57	6.43	3.78	28.73	141.9
Net Income to Common	19.59	21.57	6.43	3.78	28.73	141.9
Net Income Growth	13.45%	235.40%	70.20%	-86.85%	-79.75%	881.60%
Shares Outstanding (Basic)	14	14	14	14	13	12
Shares Outstanding (Diluted)	14	14	14	14	14	13
Shares Change (YoY)	0.34%	0.43%	-0.08%	5.81%	2.28%	4.32%
EPS (Basic)	1.37	1.51	0.45	0.26	2.21	11.65
EPS (Diluted)	1.36	1.50	0.45	0.26	2.13	10.73
EPS Growth	13.63%	236.70%	69.01%	-87.61%	-80.17%	841.57%
Free Cash Flow	30.8	53.8	8.21	-3.36	-475.02	87.27
Free Cash Flow Per Share	2.14	3.75	0.57	-0.23	-35.11	6.60
Dividend Per Share	0.300	0.509	0.400	1.018	0.827	4.604
Dividend Growth	-67.00%	27.27%	-60.71%	23.19%	-82.05%	329.44%
Gross Margin	48.03%	47.78%	42.27%	41.98%	46.61%	52.22%
Operating Margin	16.31%	17.24%	8.43%	4.46%	19.35%	32.65%
Profit Margin	9.71%	10.51%	3.73%	2.17%	11.44%	24.67%
Free Cash Flow Margin	15.26%	26.21%	4.76%	-1.93%	-189.12%	15.17%
EBITDA	47.88	51.6	31.86	25.04	61.47	195.54
EBITDA Margin	23.72%	25.14%	18.47%	14.40%	24.47%	34.00%
D&A For EBITDA	14.96	16.22	17.32	17.29	12.86	7.75
EBIT	32.93	35.38	14.54	7.75	48.61	187.79
EBIT Margin	16.31%	17.24%	8.43%	4.46%	19.35%	32.65%
Effective Tax Rate	21.33%	20.01%	18.33%	23.15%	20.08%	19.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.